IPP Bureau
Prevest Denpro launches range of innovative oral hygiene products ‘Oradox’
By IPP Bureau - November 23, 2023
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
Strides receives USFDA approval for generic Suprep bowel prep kit
By IPP Bureau - November 23, 2023
The Product will be manufactured at the company's facility in Bengaluru
Evive Biotech and Acrotech Biopharma receive FDA approval of Ryzneuta
By IPP Bureau - November 23, 2023
Lupin receives tentative approval from USFDA for Dapagliflozin Tablets
By IPP Bureau - November 22, 2023
Dapagliflozin Tablets (RLD Farxiga) had estimated annual sales of USD 7282 million in the US
Lupin receives approval from USFDA for Pitavastatin Tablets
By IPP Bureau - November 22, 2023
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
Truqap plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
By IPP Bureau - November 22, 2023
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Azelis inks distribution agreement with Beneo in India and Bangladesh
By IPP Bureau - November 22, 2023
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
LTTS, NVIDIA to unveil Gen AI and software defined architecture for medical devices
By IPP Bureau - November 21, 2023
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
Mandaviya visits Jan Aushadhi stall at IITF
By IPP Bureau - November 21, 2023
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Mandaviya visits Ayushman Bhav Health Pavilion at the 42nd IITF 2023
By IPP Bureau - November 21, 2023
Distributes Ayushman cards to several beneficiaries
AstraZeneca launches health-tech business ‘Evinova’
By IPP Bureau - November 21, 2023
Evinova will operate as a separate health-tech business within AstraZeneca
GSK receives positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia
By IPP Bureau - November 21, 2023
Decision on EU marketing authorisation expected for momelotinib by early 2024
Oceanic-AF study stopped early due to lack of efficacy
By IPP Bureau - November 21, 2023
OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
Strides receives USFDA approval for Levetiracetam Oral Solution
By IPP Bureau - November 21, 2023
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) and is used in the treatment of seizures.
Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023
By IPP Bureau - November 20, 2023
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
